Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for GERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 642.47M
March 31, 2026 641.03M
December 31, 2025 639.86M
September 30, 2025 638.36M
June 30, 2025 637.85M
March 31, 2025 636.92M
December 31, 2024 606.39M
September 30, 2024 603.10M
June 30, 2024 601.05M
March 31, 2024 591.16M
December 31, 2023 544.91M
September 30, 2023 542.48M
June 30, 2023 521.94M
March 31, 2023 508.73M
December 31, 2022 390.26M
September 30, 2022 381.21M
June 30, 2022 377.66M
March 31, 2022 323.74M
December 31, 2021 323.73M
September 30, 2021 320.60M
June 30, 2021 320.60M
March 31, 2021 318.54M
December 31, 2020 310.57M
September 30, 2020 310.47M
June 30, 2020 310.44M
Date Value
March 31, 2020 200.35M
December 31, 2019 199.81M
September 30, 2019 192.87M
June 30, 2019 182.55M
March 31, 2019 186.41M
December 31, 2018 186.39M
September 30, 2018 186.35M
June 30, 2018 182.55M
March 31, 2018 173.08M
December 31, 2017 159.88M
September 30, 2017 159.23M
June 30, 2017 159.21M
March 31, 2017 159.18M
December 31, 2016 159.16M
September 30, 2016 159.15M
June 30, 2016 159.14M
March 31, 2016 158.93M
December 31, 2015 158.78M
September 30, 2015 158.22M
June 30, 2015 158.14M
March 31, 2015 158.09M
December 31, 2014 157.43M
September 30, 2014 156.93M
June 30, 2014 156.94M
March 31, 2014 156.93M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Precigen, Inc. 358.01M
Editas Medicine, Inc. 153.53M
Agenus, Inc. 42.62M
Amgen, Inc. 540.60M
Anika Therapeutics, Inc. 13.38M